Adventitious arsenate reductase activity of the catalytic domain of the human Cdc25B and Cdc25C phosphatases

Hiranmoy Bhattacharjee, Ju Sheng, A. Abdul Ajees, Rita Mukhopadhyay, Barry P. Rosen

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

A number of eukaryotic enzymes that function as arsenate reductases are homologues of the catalytic domain of the human Cdc25 phosphatase. For example, the Leishmania major enzyme LmACR2 is both a phosphatase and an arsenate reductase, and its structure bears similarity to the structure of the catalytic domain of human Cdc25 phosphatase. These reductases contain an active site C-X5-R signature motif, where C is the catalytic cysteine, the five X residues form a phosphate binding loop, and R is a highly conserved arginine, which is also present in human Cdc25 phosphatases. We therefore investigated the possibility that the three human Cdc25 isoforms might have adventitious arsenate reductase activity. The sequences for the catalytic domains of Cdc25A, -B, and -C were cloned individually into a prokaryotic expression vector, and their gene products were purified from a bacterial host using nickel affinity chromatography. While each of the three Cdc25 catalytic domains exhibited phosphatase activity, arsenate reductase activity was observed only with Cdc25B and -C. These two enzymes reduced inorganic arsenate but not methylated pentavalent arsenicals. Alteration of either the cysteine and arginine residues of the Cys-X5-Arg motif led to the loss of both reductase and phosphatase activities. Our observations suggest that Cdc25B and -C may adventitiously reduce arsenate to the more toxic arsenite and may also provide a framework for identifying other human protein tyrosine phosphatases containing the active site Cys-X5-Arg loop that might moonlight as arsenate reductases.

Original languageEnglish
Pages (from-to)802-809
Number of pages8
JournalBiochemistry
Volume49
Issue number4
DOIs
Publication statusPublished - 02-02-2010

Fingerprint

Arsenate Reductases
cdc25 Phosphatases
Catalytic Domain
Phosphoric Monoester Hydrolases
Cysteine
Arginine
Oxidoreductases
Enzymes
Arsenicals
Affinity chromatography
Protein Tyrosine Phosphatases
Poisons
Leishmania major
Nickel
Affinity Chromatography
Protein Isoforms
Genes
Phosphates

All Science Journal Classification (ASJC) codes

  • Biochemistry

Cite this

Bhattacharjee, Hiranmoy ; Sheng, Ju ; Ajees, A. Abdul ; Mukhopadhyay, Rita ; Rosen, Barry P. / Adventitious arsenate reductase activity of the catalytic domain of the human Cdc25B and Cdc25C phosphatases. In: Biochemistry. 2010 ; Vol. 49, No. 4. pp. 802-809.
@article{e4cbfce3b29146b899e1bfc4c230143e,
title = "Adventitious arsenate reductase activity of the catalytic domain of the human Cdc25B and Cdc25C phosphatases",
abstract = "A number of eukaryotic enzymes that function as arsenate reductases are homologues of the catalytic domain of the human Cdc25 phosphatase. For example, the Leishmania major enzyme LmACR2 is both a phosphatase and an arsenate reductase, and its structure bears similarity to the structure of the catalytic domain of human Cdc25 phosphatase. These reductases contain an active site C-X5-R signature motif, where C is the catalytic cysteine, the five X residues form a phosphate binding loop, and R is a highly conserved arginine, which is also present in human Cdc25 phosphatases. We therefore investigated the possibility that the three human Cdc25 isoforms might have adventitious arsenate reductase activity. The sequences for the catalytic domains of Cdc25A, -B, and -C were cloned individually into a prokaryotic expression vector, and their gene products were purified from a bacterial host using nickel affinity chromatography. While each of the three Cdc25 catalytic domains exhibited phosphatase activity, arsenate reductase activity was observed only with Cdc25B and -C. These two enzymes reduced inorganic arsenate but not methylated pentavalent arsenicals. Alteration of either the cysteine and arginine residues of the Cys-X5-Arg motif led to the loss of both reductase and phosphatase activities. Our observations suggest that Cdc25B and -C may adventitiously reduce arsenate to the more toxic arsenite and may also provide a framework for identifying other human protein tyrosine phosphatases containing the active site Cys-X5-Arg loop that might moonlight as arsenate reductases.",
author = "Hiranmoy Bhattacharjee and Ju Sheng and Ajees, {A. Abdul} and Rita Mukhopadhyay and Rosen, {Barry P.}",
year = "2010",
month = "2",
day = "2",
doi = "10.1021/bi9019127",
language = "English",
volume = "49",
pages = "802--809",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "4",

}

Adventitious arsenate reductase activity of the catalytic domain of the human Cdc25B and Cdc25C phosphatases. / Bhattacharjee, Hiranmoy; Sheng, Ju; Ajees, A. Abdul; Mukhopadhyay, Rita; Rosen, Barry P.

In: Biochemistry, Vol. 49, No. 4, 02.02.2010, p. 802-809.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Adventitious arsenate reductase activity of the catalytic domain of the human Cdc25B and Cdc25C phosphatases

AU - Bhattacharjee, Hiranmoy

AU - Sheng, Ju

AU - Ajees, A. Abdul

AU - Mukhopadhyay, Rita

AU - Rosen, Barry P.

PY - 2010/2/2

Y1 - 2010/2/2

N2 - A number of eukaryotic enzymes that function as arsenate reductases are homologues of the catalytic domain of the human Cdc25 phosphatase. For example, the Leishmania major enzyme LmACR2 is both a phosphatase and an arsenate reductase, and its structure bears similarity to the structure of the catalytic domain of human Cdc25 phosphatase. These reductases contain an active site C-X5-R signature motif, where C is the catalytic cysteine, the five X residues form a phosphate binding loop, and R is a highly conserved arginine, which is also present in human Cdc25 phosphatases. We therefore investigated the possibility that the three human Cdc25 isoforms might have adventitious arsenate reductase activity. The sequences for the catalytic domains of Cdc25A, -B, and -C were cloned individually into a prokaryotic expression vector, and their gene products were purified from a bacterial host using nickel affinity chromatography. While each of the three Cdc25 catalytic domains exhibited phosphatase activity, arsenate reductase activity was observed only with Cdc25B and -C. These two enzymes reduced inorganic arsenate but not methylated pentavalent arsenicals. Alteration of either the cysteine and arginine residues of the Cys-X5-Arg motif led to the loss of both reductase and phosphatase activities. Our observations suggest that Cdc25B and -C may adventitiously reduce arsenate to the more toxic arsenite and may also provide a framework for identifying other human protein tyrosine phosphatases containing the active site Cys-X5-Arg loop that might moonlight as arsenate reductases.

AB - A number of eukaryotic enzymes that function as arsenate reductases are homologues of the catalytic domain of the human Cdc25 phosphatase. For example, the Leishmania major enzyme LmACR2 is both a phosphatase and an arsenate reductase, and its structure bears similarity to the structure of the catalytic domain of human Cdc25 phosphatase. These reductases contain an active site C-X5-R signature motif, where C is the catalytic cysteine, the five X residues form a phosphate binding loop, and R is a highly conserved arginine, which is also present in human Cdc25 phosphatases. We therefore investigated the possibility that the three human Cdc25 isoforms might have adventitious arsenate reductase activity. The sequences for the catalytic domains of Cdc25A, -B, and -C were cloned individually into a prokaryotic expression vector, and their gene products were purified from a bacterial host using nickel affinity chromatography. While each of the three Cdc25 catalytic domains exhibited phosphatase activity, arsenate reductase activity was observed only with Cdc25B and -C. These two enzymes reduced inorganic arsenate but not methylated pentavalent arsenicals. Alteration of either the cysteine and arginine residues of the Cys-X5-Arg motif led to the loss of both reductase and phosphatase activities. Our observations suggest that Cdc25B and -C may adventitiously reduce arsenate to the more toxic arsenite and may also provide a framework for identifying other human protein tyrosine phosphatases containing the active site Cys-X5-Arg loop that might moonlight as arsenate reductases.

UR - http://www.scopus.com/inward/record.url?scp=75149149952&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75149149952&partnerID=8YFLogxK

U2 - 10.1021/bi9019127

DO - 10.1021/bi9019127

M3 - Article

VL - 49

SP - 802

EP - 809

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 4

ER -